Content about Armodafinil

April 30, 2012
Mylan to launch generic version of Nuvigil in 2016

Mylan plans to start selling a generic version of a drug for sleep disorders starting in June 2016, under a deal with Teva announced Monday.

PITTSBURGH — Mylan plans to start selling a generic version of a drug for sleep disorders starting in June 2016, under a deal with Teva announced Monday.

Mylan said it had settled with Teva over the former's generic version of Nuvigil (armodafinil) tablets, a drug used to treat sleepiness related to sleep apnea, narcolepsy and shift work disorder.

March 30, 2011
Valeant seeks to buy Cephalon

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

MISSISSAUGA, Ontario — Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

The buyout offer, equal to $73 per share, includes a 29% premium over Cephalon’s stock price. Valeant noted it had made previous offers, but was “disappointed by Cephalon’s unwillingness to engage in discussions in a timely manner.”

October 24, 2010
FDA approves REMS for Nuvigil, Provigil

The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep...

FRAZER, Pa. The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep disorder drugs made by Cephalon, the drug maker said.

 

Cephalon announced that the FDA approved the REMS for Nuvigil (armodafinil) and Provigil (modafinil), both used to improve wakefulness in patients with sleep apnea, narcolepsy or shift work disorder.

 

 

March 29, 2010
Jet lag treatment receives complete response letter

The Food and Drug Administration declined to approve a Cephalon drug as a treatment for...

January 10, 2010
Mylan confirms first-to-file patent challenge for Nuvigil generic

Drug maker Cephalon and its French subsidiary sued generic drug maker Mylan in connection with...

January 5, 2010
Watson seeks FDA approval for sleep disorder treatment

Watson has filed an abbreviated new drug application for the generic version of a sleep...